Important Peer Reviewed Study on Nozin Nasal Sanitizer® Antiseptic is Published


A safe, effective, non-antibiotic method for nasal carriage reduction.

The Medical University of South Carolina study using Nozin Nasal Sanitizer® antiseptic is now a major article in the August 2014 issue of the American Journal Of Infection Control. The conclusion in the peer reviewed study included the observation that the ability of Nozin Nasal Sanitizer® antiseptic to reduce nasal bacteria carriage suggested  "the usefulness of this approach as a safe, effective, and convenient alternative to antibiotic treatment."

In a double-blind, placebo controlled, independent clinical study by investigators at the Medical University of South Carolina, Nozin® Nasal Sanitizer® antiseptic was effective in significantly reducing Staph aureus nasal carriage in health care providers (HCPs).  The results demonstrate that the administration of this nonantibiotic antiseptic (Nozin Nasal Sanitizer) was effective in reducing S. aureus and total bacteria in a single-day application protocol.  The publication of the study can be found in the American Journal of Infection Control as a major article titled: Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic.

Nozin Nasal Sanitizer PopSwab ampule

Nozin® Nasal Sanitizer® PopSwab® ampule

Why are these results significant?   It is commonly believed that the primary reservoir for the pathogen Staph aureus is the vestibule of the nose.  Now, it has been shown that carriage can be reduced using a commercially available ethanol based antiseptic, Nozin Nasal Sanitizer.  Additionally, use of this trusted antiseptic will not likely contribute to the rise in antibiotic resistance, an important issue in infection control. As stated in another study on the role of nasal carriage,  "Staphylococcus aureus is a frequent cause of infections in both the community and hospital. Worldwide, the increasing resistance of this pathogen to various antibiotics complicates treatment of S. aureus infections. Effective measures to prevent S. aureus infections are therefore urgently needed. It has been shown that nasal carriers of S. aureus have an increased risk of acquiring an infection with this pathogen. The nose is the main ecological niche where S. aureus resides in human beings..."1 

The positive results from the Medical University of South Carolina study published in the American Journal of Infection Control indicate the potential of Nozin Nasal Sanitizer as a tool in helping to reduce infections in healthcare settings, a paradigm that Nozin scientists have been promoting for years. This third party, peer-reviewed validation of the efficacy of Nasal Sanitizer® and Nozaseptin™ technology further supports use of Nozin Nasal Sanitizer® as a safe and effective non-antibiotic treatment.  

1. Wertheim, HF et al. The role of nasal carriage in Staphylococcus aureus infections.  2005 Dec;5(12):751-62.

Learn more about Nasal Sanitizer®

We encourage you to explore the entire site. Read the Frequently Asked Questions page and the Product Information page. Of course, feel free to contact us with any questions or comments you may have.

© 2004-2023 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease.